StockCIK 1395064
TAKEDA PHARMACEUTICAL CO LTD (TAK): Insider Trades and Fund Holdings
In the past 12 months, TAKEDA PHARMACEUTICAL CO LTD insiders reported 0 open-market purchases worth $0 and 4 sales worth $3.39M; 2 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$3.39MSold by insiders, 12 months
1Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 15, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Sep 15 | Lauren Rusckowski DupreyChief Transformation Officer | ▼ SELL | $640K |
| Sep 3 | Andrew Stewart PlumpPresident | ▼ SELL10b5-1 | $2.15M |
| Aug 21 | Andrew Stewart PlumpPresident | ▼ SELL10b5-1 | $363K |
| Aug 19 | Nicola Deidre Petal GreenwayChief Human Resources Officer | ▼ SELL | $235K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Lauren Rusckowski Duprey | Chief Transformation Officer | 0 | $0 | 1 | $640K |
| Andrew Stewart Plump | President | 0 | $0 | 2 | $2.51M |
| Nicola Deidre Petal Greenway | Chief Human Resources Officer | 0 | $0 | 1 | $235K |
ADVERTISEMENT
320 × 100 ad slot
Tracked funds that report TAK
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 2,568,000 | $41.2M | ▼ −14.1% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →